The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experience
- PMID: 28551815
- DOI: 10.1007/s10147-017-1134-x
The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experience
Abstract
Background: There are no guidelines about the selection of recurrent cervical cancer patients for salvage surgery.
Methods: Patients who developed recurrent or persistent cervical cancer in a previously irradiated field and were subsequently treated with salvage surgery (the surgery group) or palliative care alone (the palliative group) were identified. Patient characteristics, treatment-related complications, and survival were retrospectively compared between the two groups.
Results: A total of 79 patients (surgery group, n = 51; palliative group, n = 28) were identified. In the surgery group, no intraoperative complications or treatment-related deaths occurred. Eleven patients (21.6%) experienced severe postoperative complications. After a median follow-up period of 41.5 months, 23 patients (45.1%) had developed recurrent disease, predominantly at distant sites, and 19 patients (37.3%) had died of disease progression. The estimated 3-year progression-free survival (PFS) and overall survival rates of the surgery group were 50.4 and 56.5%, respectively. In the palliative group, all of the patients died of disease progression. Positive surgical margins and lymph node metastasis were found to be independent prognostic factors for PFS in the surgery group. Among the patients with no or one poor prognostic factor, the patients in the surgery group survived significantly longer than those in the palliative group. However, among the patients with 2 poor prognostic factors, the surgery group and palliative group displayed similar survival periods.
Conclusions: Salvage surgery is a curative treatment in recurrent or persistent cervical cancer patients. However, considering its high surgical complication rate, salvage surgery should only be offered to carefully selected patients.
Keywords: Oncological outcome; Palliative care; Recurrent or persistent cervical cancer; Salvage surgery; Surgical outcome.
Similar articles
-
Radical hysterectomy after radiotherapy for recurrent or persistent cervical cancer.Int J Gynaecol Obstet. 2017 Nov;139(2):185-191. doi: 10.1002/ijgo.12284. Epub 2017 Sep 6. Int J Gynaecol Obstet. 2017. PMID: 28755426
-
Indications for primary and secondary exenterations in patients with cervical cancer.Gynecol Oncol. 2006 Dec;103(3):1023-30. doi: 10.1016/j.ygyno.2006.06.027. Epub 2006 Aug 4. Gynecol Oncol. 2006. PMID: 16890276
-
Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy.Curr Oncol. 2022 Jul 11;29(7):4856-4867. doi: 10.3390/curroncol29070385. Curr Oncol. 2022. PMID: 35877245 Free PMC article.
-
Recurrent cervical cancer.Curr Treat Options Oncol. 2002 Apr;3(2):105-11. doi: 10.1007/s11864-002-0056-6. Curr Treat Options Oncol. 2002. PMID: 12057073 Review.
-
Surgical aspects of cervical cancer.Surg Clin North Am. 1991 Oct;71(5):1067-83. doi: 10.1016/s0039-6109(16)45535-0. Surg Clin North Am. 1991. PMID: 1925852 Review.
Cited by
-
Assessment of Salvage Surgery in Persistent Cervical Cancer after Definitive Radiochemotherapy: A Systematic Review.Medicina (Kaunas). 2023 Jan 18;59(2):192. doi: 10.3390/medicina59020192. Medicina (Kaunas). 2023. PMID: 36837394 Free PMC article.
-
Multimodality treatment for multiple recurrences of cervical cancer after radiotherapy: a case report.Transl Cancer Res. 2022 Apr;11(4):943-951. doi: 10.21037/tcr-21-2250. Transl Cancer Res. 2022. PMID: 35571661 Free PMC article.
-
Selection of Treatment Regimens for Recurrent Cervical Cancer.Front Oncol. 2021 Feb 2;11:618485. doi: 10.3389/fonc.2021.618485. eCollection 2021. Front Oncol. 2021. PMID: 33604304 Free PMC article.
-
Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience.Front Oncol. 2022 Jul 19;12:943703. doi: 10.3389/fonc.2022.943703. eCollection 2022. Front Oncol. 2022. PMID: 35928866 Free PMC article.
-
Impact of a reduction in follow-up frequency on life expectancy in uterine cervical cancer patients.Int J Clin Oncol. 2020 Jun;25(6):1170-1177. doi: 10.1007/s10147-020-01641-w. Epub 2020 Mar 9. Int J Clin Oncol. 2020. PMID: 32152766
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical